Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of gut microbiome on immunotherapy efficacy in melanoma.
Bibbò S, Ianiro G, Giambò F, Settanni CR, Cammarota G, Gasbarrini A. Bibbò S, et al. Among authors: gasbarrini a. Hum Vaccin Immunother. 2022 May 31;18(3):1926759. doi: 10.1080/21645515.2021.1926759. Epub 2021 Jun 30. Hum Vaccin Immunother. 2022. PMID: 34190675 Free PMC article. Review.
New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
Gasbarrini G, Malfertheiner P, Deltenre M, Mégraud F, O'Morain C, Pajares-García J, Quina M, Bianchi Porro G, Gasbarrini A, Franceschi F, Armuzzi A, Cammarota G, Anti M, Pretolani S. Gasbarrini G, et al. Among authors: gasbarrini a. Ital J Gastroenterol Hepatol. 1998 Oct;30 Suppl 3:S244-7. Ital J Gastroenterol Hepatol. 1998. PMID: 10077746 Review. No abstract available.
Helicobacter pylori infection and ischaemic heart disease.
Cammarota G, Pasceri V, Papa A, Cianci R, Gasbarrini A, Fedeli P, Cremonini F, Fedeli G, Maseri A, Gasbarrini G. Cammarota G, et al. Among authors: gasbarrini a, gasbarrini g. Ital J Gastroenterol Hepatol. 1998 Oct;30 Suppl 3:S304-6. Ital J Gastroenterol Hepatol. 1998. PMID: 10077760 Review.
Role of sucralfate in gastrointestinal diseases.
Candelli M, Carloni E, Armuzzi A, Cammarota G, Ojetti V, Pignataro G, Santoliquido A, Pola R, Pola E, Gasbarrini G, Gasbarrini A. Candelli M, et al. Among authors: gasbarrini a, gasbarrini g. Panminerva Med. 2000 Mar;42(1):55-9. Panminerva Med. 2000. PMID: 11019606 Review.
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.
Di Caro S, Ojetti V, Zocco MA, Cremonini F, Bartolozzi F, Candelli M, Lupascu A, Nista EC, Cammarota G, Gasbarrini A. Di Caro S, et al. Among authors: gasbarrini a. Aliment Pharmacol Ther. 2002 Mar;16(3):527-32. doi: 10.1046/j.1365-2036.2002.01165.x. Aliment Pharmacol Ther. 2002. PMID: 11876707 Free article. Clinical Trial.
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.
Lauritano EC, Gabrielli M, Lupascu A, Santoliquido A, Nucera G, Scarpellini E, Vincenti F, Cammarota G, Flore R, Pola P, Gasbarrini G, Gasbarrini A. Lauritano EC, et al. Among authors: gasbarrini a, gasbarrini g. Aliment Pharmacol Ther. 2005 Jul 1;22(1):31-5. doi: 10.1111/j.1365-2036.2005.02516.x. Aliment Pharmacol Ther. 2005. PMID: 15963077 Free article. Clinical Trial.
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.
Scarpellini E, Gabrielli M, Lauritano CE, Lupascu A, Merra G, Cammarota G, Cazzato IA, Gasbarrini G, Gasbarrini A. Scarpellini E, et al. Among authors: gasbarrini a, gasbarrini g. Aliment Pharmacol Ther. 2007 Apr 1;25(7):781-6. doi: 10.1111/j.1365-2036.2007.03259.x. Aliment Pharmacol Ther. 2007. PMID: 17373916 Free article. Clinical Trial.
Nutritional aspects of Helicobacter pylori infection.
Vitale G, Barbaro F, Ianiro G, Cesario V, Gasbarrini G, Franceschi F, Gasbarrini A. Vitale G, et al. Among authors: gasbarrini a, gasbarrini g. Minerva Gastroenterol Dietol. 2011 Dec;57(4):369-77. Minerva Gastroenterol Dietol. 2011. PMID: 22105725 Review.
1,718 results